1
|
Blanco N, Lavoie MC, Ngeno C, Wangusi R, Jumbe M, Kimonye F, Ndaga A, Ndichu G, Makokha V, Awuor P, Momanyi E, Oyuga R, Nzyoka S, Mutisya I, Joseph R, Miruka F, Musingila P, Stafford KA, Lascko T, Ngunu C, Owino E, Kiplangat A, Abuya K, Koech E. Effects of Multi-Month Dispensing on Clinical Outcomes: Retrospective Cohort Analysis Conducted in Kenya. AIDS Behav 2024; 28:583-590. [PMID: 38127168 PMCID: PMC11318087 DOI: 10.1007/s10461-023-04247-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/02/2023] [Indexed: 12/23/2023]
Abstract
Multi-month dispensing (MMD) has been widely adopted by national HIV programs as a key strategy for improving the quality of HIV care and treatment services while meeting the unique needs of diverse client populations. We assessed the clinical outcomes of clients receiving MMD in Kenya by conducting a retrospective cohort study using routine programmatic data in 32 government health facilities in Kenya. We included clients who were eligible for multi-month antiretroviral therapy (ART) dispensing for ≥ 3 months (≥ 3MMD) according to national guidelines. The primary exposure was enrollment into ≥ 3MMD. The outcomes were lost to follow-up (LTFU) and viral rebound. Multilevel modified-Poisson regression models with robust standard errors were used to compare clinical outcomes between clients enrolled in ≥ 3MMD and those receiving ART dispensing for less than 3 months (< 3MMD). A total of 3,501 clients eligible for ≥ 3MMD were included in the analysis, of whom 65% were enrolled in ≥ 3MMD at entry into the cohort. There was no difference in LTFU of ≥ 180 days between the two types of care (aRR 1.1, 95% CI 0.7-1.6), while ≥ 3MMD was protective for viral rebound (aRR 0.1 95% CI 0.0-0.2). As more diverse client-focused service delivery models are being implemented, robust evaluations are essential to guide the implementation, monitor progress, and assess acceptability and effectiveness to deliver optimal people-centered care.
Collapse
Affiliation(s)
- Natalia Blanco
- Centre for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, USA.
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
| | - M C Lavoie
- Centre for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, USA
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
- Division of Global Health Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
| | - C Ngeno
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - R Wangusi
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - M Jumbe
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - F Kimonye
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - A Ndaga
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - G Ndichu
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - V Makokha
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - P Awuor
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - E Momanyi
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - R Oyuga
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - S Nzyoka
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - I Mutisya
- Division of Global HIV & TB (DGHT), U.S. Centers for Disease Control and Prevention (CDC), Nairobi, Kenya
| | - R Joseph
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| | - F Miruka
- Division of Global HIV & TB (DGHT), U.S. Centers for Disease Control and Prevention (CDC), Nairobi, Kenya
| | - P Musingila
- Division of Global HIV & TB (DGHT), U.S. Centers for Disease Control and Prevention (CDC), Nairobi, Kenya
| | - K A Stafford
- Centre for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, USA
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
- Division of Global Health Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
| | - T Lascko
- Centre for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, USA
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
| | - C Ngunu
- Nairobi Metropolitan Services Health Management Team, Nairobi, Kenya
| | - E Owino
- Migori County Health Management Team, Western, Kenya
| | - A Kiplangat
- Nairobi Metropolitan Services Health Management Team, Nairobi, Kenya
| | - K Abuya
- Kisii County Health Management Team, Western, Kenya
| | - E Koech
- Center for International Health Education and Biosecurity (Ciheb), MGIC-an affiliate of the University of Maryland Baltimore, Nairobi, Kenya
| |
Collapse
|
2
|
Mantell JE, Zech JM, Masvawure TB, Assefa T, Molla M, Block L, Duguma D, Yirsaw Z, Rabkin M. Implementing six multi-month dispensing of antiretroviral therapy in Ethiopia: perspectives of clients and healthcare workers. BMC Health Serv Res 2023; 23:563. [PMID: 37259098 DOI: 10.1186/s12913-023-09549-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2022] [Accepted: 05/14/2023] [Indexed: 06/02/2023] Open
Abstract
BACKGROUND Multi-month dispensing (MMD) of antiretroviral therapy (ART) is an integral component of differentiated HIV service delivery for people living with HIV (PLHIV). Although many countries have scaled up ART dispensing to 3-month intervals, Ethiopia was the first African country to implement six-month dispensing (6-MMD) at scale, introducing its Appointment Spacing Model (ASM) for people doing well on ART in 2017. As of June 2021, 51.4% (n = 215,101) of PLHIV on ART aged ≥ 15 years had enrolled in ASM. Since little is known about the benefits and challenges of ASM perceived by Ethiopian clients and their healthcare workers (HCWs), we explored how the ASM was being implemented in Ethiopia's Oromia region in September 2019. METHODS Using a parallel convergent mixed-methods study design, we conducted 6 focus groups with ASM-eligible enrolled clients, 6 with ASM-eligible non-enrolled clients, and 22 in-depth interviews with HCWs. Data were audio-recorded, transcribed and translated into English. We used thematic analysis, initially coding deductively, followed by inductive coding of themes that emerged from the data, and compared the perspectives of ASM-enrolled and non-enrolled clients and their HCWs. RESULTS Participants enrolled in ASM and HCWs perceived client-level ASM benefits to include time and cost-savings, fewer work disruptions, reduced stigma due to fewer clinic visits, better medication adherence and improved overall health. Perceived health system-level benefits included improved quality of care, decongested facilities, reduced provider workloads, and improved record-keeping. Although non-enrolled participants anticipated many of the same benefits, their reasons for non-enrollment included medication storage challenges, concerns over less frequent health monitoring, and increased stress due to the large quantities of medicines dispensed. Enrolled participants and HCWs identified similar challenges, including client misunderstandings about ASM and initial ART stock-outs. CONCLUSIONS ASM with 6-MMD was perceived to have marked benefits for clients and health systems. Clients enrolled in the ASM and their HCWs had positive experiences with the model, including perceived improvements in efficiency, quality and convenience of HIV treatment services. The concerns of non-ASM enrolled participants suggest the need for enhanced client education about the model and more discreet and efficiently packaged ART and highlight that ASM is not ideal for all clients.
Collapse
Affiliation(s)
- Joanne E Mantell
- New York State Psychiatric Institute and Department of Psychiatry, HIV Center for Clinical and Behavioral Studies, Gender, Sexuality and Health Area, Columbia University Irving Medical Center, New York, New York, United States of America.
| | - Jennifer M Zech
- ICAP at Columbia University, New York, NY, United States of America
| | - Tsitsi B Masvawure
- Health Studies Program, Center for Interdisciplinary Studies, College of the Holy Cross, Worcester, MA, United States of America
| | | | | | - Laura Block
- ICAP at Columbia University, New York, NY, United States of America
| | | | | | - Miriam Rabkin
- ICAP at Columbia University, New York, NY, United States of America
- Departments of Medicine and Epidemiology, Columbia University Irving Medical Center, New York, NY, United States of America
| |
Collapse
|
3
|
Asrade AA, Moges NA, Meseret M, Alemu KD, Tsega TD, Petrucka P, Telayneh AT. Uptake of appointment spacing model of care and associated factors among stable adult HIV clients on antiretroviral treatment Northwest Ethiopia. PLoS One 2022; 17:e0279760. [PMID: 36584153 PMCID: PMC9803219 DOI: 10.1371/journal.pone.0279760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Accepted: 12/14/2022] [Indexed: 12/31/2022] Open
Abstract
INTRODUCTION Ethiopia launched an Appointment Spacing Model in 2017, which involved a six-month clinical visit and medication refill cycle. This study aimed to assess the uptake of the Appointment Spacing Model of care and associated factors among stable adult HIV clients on ART in Ethiopia. METHODS A cross-sectional study was conducted from October 3 to November 30, 2020 among 415 stable adult ART clients. EpiData version 4.2 was used for data entry and SPSS version 25 was used for cleaning and analysis. A multivariable logistic regression model was fitted to identify associated factors, with CI at 95% with AOR being reported to show the strength of association. RESULTS The uptake of the appointment spacing model was 50.1%. Residence [AOR: 2.33 (95% CI: 1.27, 4.26)], monthly income [AOR: 2.65 (95% CI: 1.13, 6.24)], social support [AOR: 2.21 (95% CI: 1.03, 4.71)], duration on ART [AOR: 2.41 (95% CI: 1.48, 3.92)], baseline regimen change [AOR: 2.20 (95% CI: 1.02, 4.78)], viral load [AOR: 2.80 (95% CI: 1.06, 7.35)], and alcohol abstinence [AOR: 2.02 (95% CI: 1.21, 3.37)] were statistically significant. CONCLUSIONS The uptake of the ASM was low. Behavioral change communication, engaging income-generating activities, and facility-level service providers' training may improve the uptake.
Collapse
Affiliation(s)
- Abaynew Assemu Asrade
- HIV/AIDS Care Program, International Center for AIDS Care Program, Bahir Dar, Ethiopia
| | - Nurilign Abebe Moges
- Department of Public Health, College of Health Sciences, Debre Markos University, Debre Marqos, Ethiopia
| | - Maru Meseret
- Department of Health Informatics, College of Health Sciences, Debre Markos University, Debre Marqos, Ethiopia
| | - Kasaye Demeke Alemu
- HIV/AIDS Care Program, International Center for AIDS Care Program, Bahir Dar, Ethiopia
| | | | - Pammla Petrucka
- College of Nursing, University of Saskatchewan, Saskatoon, Canada
- School of Life Sciences and Bioengineering, Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania
| | - Animut Takele Telayneh
- Department of Public Health, College of Health Sciences, Debre Markos University, Debre Marqos, Ethiopia
- * E-mail:
| |
Collapse
|
4
|
Okere NE, Corball L, Kereto D, Hermans S, Naniche D, Rinke de Wit TF, Gomez GB. Patient-incurred costs in a differentiated service delivery club intervention compared to standard clinical care in Northwest Tanzania. J Int AIDS Soc 2021; 24:e25760. [PMID: 34164916 PMCID: PMC8222647 DOI: 10.1002/jia2.25760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Revised: 05/04/2021] [Accepted: 05/25/2021] [Indexed: 11/07/2022] Open
Abstract
INTRODUCTION Placing all clients with a positive diagnosis for HIV on antiretroviral therapy (ART) has cost implications both for patients and health systems, which could, in turn, affect feasibility, sustainability and uptake of new services. Patient-incurred costs are recognized barriers to healthcare access. Differentiated service delivery (DSD) models in general and community-based care in particular, could reduce these costs. We aimed to assess patient-incurred costs of a community-based DSD intervention (clubs) compared to clinic-based care in the Shinyanga region, Tanzania. METHODS Cross-sectional survey among stable ART patients (n = 390, clinic-based; n = 251, club-based). For each group, we collected socio-demographic, income and expenditure data between May and August 2019. We estimated direct and indirect patient-incurred costs. Direct costs included out-of-pocket expenditures. Indirect costs included income loss due to time spent during transport, accessing services and off work during illness. Cost drivers were assessed in multivariate regression models. RESULTS Overall, costs were significantly higher among clinic participants. Costs (USD) per year for clinic versus club were as follows: 11.7 versus 4.17 (p < 0.001) for direct costs, 20.9 versus 8.23 (p < 0.001) for indirect costs and 32.2 versus 12.4 (p < 0.001) for total costs. Time spent accessing care and time spent in illness (hours/year) were 38.3 versus 13.8 (p < 0.001) and 16.0 versus 6.69 (p < 0.001) respectively. The main cost drivers included transportation (clinic vs. club: 67.7% vs. 44.1%) for direct costs and income loss due to time spent accessing care (clinic vs. club: 60.4% vs. 56.7%) for indirect costs. Factors associated with higher total costs among patients attending clinic services were higher education level (coefficient [95% confidence interval]) 20.9 [5.47 to 36.3]) and formal employment (44.2 [20.0 to 68.5). Differences in mean total costs remained significantly higher with formal employment, rural residence, in addition to more frequent visits among clinic participants. The percentage of households classified as having had catastrophic expenditures in the last year was low but significantly higher among clinic participants (10.8% vs. 5.18%, p = 0.014). CONCLUSIONS Costs incurred by patients accessing DSD in the community are significantly lower compared to those accessing standard clinic-based care. DSD models could improve access, especially in resource-limited settings.
Collapse
Affiliation(s)
- Nwanneka E Okere
- Amsterdam Institute for Global Health and DevelopmentDepartment of Global HealthAmsterdam UMCUniversity of AmsterdamAmsterdamNetherlands
| | - Lucia Corball
- Amsterdam Institute for Global Health and DevelopmentDepartment of Global HealthAmsterdam UMCUniversity of AmsterdamAmsterdamNetherlands
| | | | - Sabine Hermans
- Amsterdam Institute for Global Health and DevelopmentDepartment of Global HealthAmsterdam UMCUniversity of AmsterdamAmsterdamNetherlands
| | - Denise Naniche
- ISGLOBAL‐Barcelona Institute for Global HealthHospital ClinicUniversity of BarcelonaBarcelonaSpain
| | - Tobias F Rinke de Wit
- Amsterdam Institute for Global Health and DevelopmentDepartment of Global HealthAmsterdam UMCUniversity of AmsterdamAmsterdamNetherlands
| | - Gabriela B Gomez
- Department of Global Health and DevelopmentLondon School of Hygiene and Tropical MedicineLondonUnited Kingdom
- Present address:
Vaccine epidemiology and modelling DepartmentSanofi PasteurLyonFrance
| |
Collapse
|